.svg){kind=small}
One month on from Richmond's opening event, which saw leading industry bodies and stakeholders convene, the CRO has been busy settling in their first patients at the new London Bridge site.Clinical work commenced on the 25th March with volunteers commenting on the excellent transport links and fantastic new location in the heart of London Bridge.
.avif)
Latest news
Participant-Centred Recruitment and Retention: Driving Faster Answers in Clinical Trials.
December 18, 2025
Richmond Pharmacology is proud to announce the publication of an editorial by Elizabeth Romano, Director of Communications and Participant Engagement, in the Winter 2025 issue of the Journal for Clinical Studies.
Read moreEvents
JSCPT 2025
5 – 6 December 2025
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
View event
